Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
171/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2026/398 frá 18. febrúar 2026 um breytingu á framkvæmdarreglugerð (ESB) nr. 686/2012 að því er varðar að úthluta til aðildarríkjanna mati á metkónasóli og kínólín-8-óli í tengslum við málsmeðferð við endurnýjun
Durchführungsverordnung (EU) 2026/398 der Kommission vom 18. Februar 2026 zur Änderung der Durchführungsverordnung (EU) Nr. 686/2012 betreffend die Übertragung der Überprüfung von Metconazol und Chinolin-8-ol auf Mitgliedstaaten für die Zwecke des Erneuerungsverfahrens
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.